Ophthalmological and Otological Manifestations in the Antiphospholipid Syndrome
Journal:
Current Rheumatology Reviews
Volume:
6
Page:
32-41
Author(s):
Alfredo Montehermoso and Juan Carlos Mejia
Monoclonal Antibodies in Rare Acquired Thrombotic Disorders: The Paradigms of Paroxysmal Nocturnal Hemoglobinuria, Thrombotic Thrombocytopenic Purpura and Central Retinal Vein Occlusion
Journal:
Current Vascular Pharmacology
Volume:
8
Page:
51-58
Author(s):
Panayiotis D. Ziakas, Petros Kopterides and Michael Voulgarelis
Current Molecular Understanding and Future Treatment Strategies for Pathologic Ocular Neovascularization
Journal:
Current Molecular Medicine
Volume:
9
Page:
973-981
Author(s):
Michael J. Tolentino
CB-12181, a New Azasugar-Based Matrix Metalloproteinase/Tumor Necrosis Factor-α Converting Enzyme Inhibitor, Inhibits Vascular Endothelial Growth Factor-Induced Angiogenesis in Vitro and Retinal Neovascularization in Vivo
Journal:
Current Neurovascular Research
Volume:
6
Page:
140-147
Author(s):
Yuichi Chikaraishi, Masamitsu Shimazawa, Koichi Yokota, Koichiro Yoshino and Hideaki Hara
Intravitreal Inserts of Steroids to Treat Diabetic Macular Edema
Journal:
Current Diabetes Reviews
Volume:
5
Page:
26-32
Author(s):
Javier A. Montero and Jose M. Ruiz-Moreno
Intravitreal Bevacizumab for Diabetic Retinopathy
Journal:
Current Diabetes Reviews
Volume:
5
Page:
39-46
Author(s):
J. Fernando Arevalo and Rafael A. Garcia-Amaris
Anti-angiogenic Drugs as an Adjunctive Therapy in the Surgical Treatment of Diabetic Retinopathy
Journal:
Current Diabetes Reviews
Volume:
5
Page:
52-56
Author(s):
Marta S. Figueroa, Ines Contreras and Susana Noval
Antibodies for Therapeutic Uses and the Evolution of Biotechniques
Journal:
Current Medicinal Chemistry
Volume:
16
Page:
753-779
Author(s):
P. Nieri, D. Donadio, S. Rossi, B. Adinolfi and A. Podesta
The Valsalva Maneuver and Alzheimers Disease: Is there a link?
Journal:
Current Alzheimer Research
Volume:
6
Page:
59-68
Author(s):
Peter Wostyn, Kurt Audenaert and Peter Paul De Deyn
State of the Art Clinical Efficacy and Safety Evaluation of N-Acetylcarnosine Dipeptide Ophthalmic Prodrug. Principles for the Delivery, Self-Bioactivation, Molecular Targets and Interaction with a Highly Evolved Histidyl-Hydrazide Structure in the Treatment and Therapeutic Management of a Group of Sight-Threatening Eye Diseases
Journal:
Current Clinical Pharmacology
Volume:
4
Page:
4-37
Author(s):
Mark A. Babizhayev and Anne Kasus-Jacobi